Meeting Report
Leukemia (2005) 19, 1145–1152. doi:10.1038/sj.leu.2403783 Published online 5 May 2005
The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005
M Aricó1, A Baruchel2, Y Bertrand3, A Biondi1, V Conter1, T Eden4, H Gadner5, P Gaynon6, K Horibe7, S P Hunger6, G Janka-Schaub8, G Masera1, J Nachman6, R Pieters9, M Schrappe5, K Schmiegelow10, M G Valsecchi1 and C-H Pui11
- 1Associazione Italiana di Ematologia ed Oncologia Pediatrica, Italy
- 2French Acute Lymphoblastic Leukemia Study Group, France
- 3European Organization for Research and Treatment of Cancer – Childhood Leukemia Cooperative Group
- 4Medical Research Council/National Cancer Research Institute, United Kingdom Acute Lymphoblastic Leukemia Working Party, UK
- 5Berlin–Frankfurt–Münster Group, Germany and Austria
- 6Children's Oncology Group, USA
- 7Japan Association of Childhood Leukemia Study, Japan
- 8Cooperative Acute Lymphoblastic Leukemia Study Group, Germany
- 9Dutch Childhood Oncology Group, the Netherlands
- 10Nordic Society of Pediatric Haematology and Oncology
- 11St Jude Children's Research Hospital, Memphis, TN, USA
Correspondence: Dr M Aricó, UO Onco-Ematologia Pediatrica, Ospedale dei Bambini 'G Di Cristina', Via Benedettini 1, 90134 Palermo, Italy; Fax: +39 091 6666 001; E-mail: arico@ospedalecivicopa.org
Received 8 March 2005; Accepted 9 March 2005; Published online 5 May 2005.
Abstract
Between 1995 and 2004, six International Childhood Acute Lymphoblastic Leukemia (ALL) Workshop have been held, and the completion of several collaborative projects has established the clinical relevance and treatment options for several specific genetic subtypes of ALL. This meeting report summarizes the data presented in the seventh meeting and the discussion.
Keywords:
childhood acute lymphoblastic leukemia, minimal residual disease, glucocorticoids, methotrexate, anthracycline, intrathecal therapy
